摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

bis(3,5-diisopropylpyrazol-1-yl)methane | 586956-60-7

中文名称
——
中文别名
——
英文名称
bis(3,5-diisopropylpyrazol-1-yl)methane
英文别名
1-[[3,5-Di(propan-2-yl)pyrazol-1-yl]methyl]-3,5-di(propan-2-yl)pyrazole
bis(3,5-diisopropylpyrazol-1-yl)methane化学式
CAS
586956-60-7
化学式
C19H32N4
mdl
——
分子量
316.49
InChiKey
XBYIUWJZXPSGOQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    47-49 °C(Solv: ligroine (8032-32-4))
  • 沸点:
    408.5±33.0 °C(Predicted)
  • 密度:
    1.03±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    23
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    35.6
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    bis(3,5-diisopropylpyrazol-1-yl)methane三乙基氯化锡 在 n-butyllithium 作用下, 以 四氢呋喃正己烷 为溶剂, 以38%的产率得到Et3SnCH(3,5-(i-Pr)2Pz)2
    参考文献:
    名称:
    甲碳上有机锡基团修饰的双(吡唑-1-基)甲烷与W(CO)5 THF的反应生成新型异双核有机金属配合物
    摘要:
    通过使双(吡唑-1-基)甲基锂与有机锡卤化物反应,合成了在次甲基碳上具有有机锡基团的一系列新的双(吡唑-1-基)甲烷。已经详细研究了它们与W(CO)5 THF的反应,表明这些新的配体在用W(CO)5 THF处理后显示出多种反应活性,这取决于锡原子上取代基的性质。用W(CO)5 THF处理三芳基锡烷基双(吡唑-1-基)甲烷Ar 3 SnCHPz 2(Ar =苯基或对甲苯基; Pz =取代的吡唑)导致氧化锡碳(sp 3)结合到钨(0)中心以产生新型金属-金属键合配合物CHPz 2(CO)3 W-SnAr 3,其中发现了四元金属环,而双(吡唑-1-基)甲基化物起三齿态的作用单阴离子κ 3 - [N,C,N]螯合配体。当在吡唑环的4-位上存在烷基取代基时,可以分离出一些脱羰基中间体Ar 3 SnCHPz 2 W(CO)4。顺序地加热这些中间体也可以导致氧化加成的锡-碳(SP的3)键合到钨(0)中心,这意味着锡-碳的氧化加成反应(SP
    DOI:
    10.1021/om030221o
  • 作为产物:
    描述:
    二氯甲烷3,5-二异丙基吡唑四丁基硫酸氢铵 、 sodium hydroxide 作用下, 以 为溶剂, 以37%的产率得到bis(3,5-diisopropylpyrazol-1-yl)methane
    参考文献:
    名称:
    Copper Binding Agents Acting as Copper Ionophores Lead to Caspase Inhibition and Paraptotic Cell Death in Human Cancer Cells
    摘要:
    We report a quantitative structure activity relationship study of a new class of pyrazole-pyridine copper complexes that establishes a clear correlation between the ability to promote copper accumulation and cytotoxicity. Intracellular metal accumulation is maximized when ligand lipophilicity allows the complex to rapidly cross the membrane. Copper and ligand follow different uptake kinetics and reach different intracellular equilibrium concentrations. These results support a model in which the ligand acts as an ionophore for the metal ion, cycling between intra- and extracellular compartments as dissociated or complexed entities. When treating cancer cells with structurally unrelated disulfiram and pyrazole-pyridine copper complexes, as well as with inorganic copper, the same morphological and molecular changes were reproduced, indicating that copper overload is responsible for the cytotoxic effects. Copper-based treatments drive sensitive cancer cells toward paraptotic cell death, a process hallmarked by endoplasmic reticulum stress and massive vacuolization in the absence of apoptotic features. A lack of caspase activation, as observed in copper-treated dying cells, is a consequence of metal-mediated inhibition of caspase-3. Thus, copper acts simultaneously as an endoplasmic reticulum (ER) stress inducer and a caspase-3 inhibitor, forcing the cell into caspase-independent paraptotic death. The establishment of a mechanism of action common to different copper binding agents provides a rationale for the exploitation of copper toxicity as an anticancer tool.
    DOI:
    10.1021/ja109413c
点击查看最新优质反应信息

文献信息

  • Synthesis of acyl iron complexes based on bis(heteroaryl)methanes
    作者:Da-Wei Zhao、Xia-Li Liu、Xiao-Yan Zhang、Liang-Fu Tang
    DOI:10.1016/j.jorganchem.2014.12.039
    日期:2015.3
    lithiation of bis(pyrazol-1-yl)methanes, bis(1-methylimidazol-2-yl)methane [CH2(mim)2] and 2-(3,5-dimethylpyrazol-1-ylmethyl)pyridine [CH2(3,5-Me2Pz)(Py)] using n-BuLi at low temperature, with iron carbonyl and iodine resulted in significantly different acyl iron derivatives. Reaction of bis(pyrazol-1-yl)methanes with n-BuLi, and subsequently with iron carbonyl and iodine yielded bis(pyrazol-1-yl)acyl
    锂盐的处理,其衍生自双(吡唑-1-基)甲烷,双(1-甲基咪唑-2-基)甲烷[CH 2(mim)2 ]和2-(3,5-二甲基吡唑-在低温下使用正丁基锂与羰基铁和碘作用的1-基甲基)吡啶[CH 2(3,5-Me 2 Pz)(Py)]产生明显不同的酰基铁衍生物。双(吡唑-1-基)甲烷与正丁基锂反应,然后与羰基铁和碘反应生成双(吡唑-1-基)酰基铁络合物,而类似的CH 2(mim)2反应则得到戊基铁络合物CH 2(mim)2 Fe(CO)2(COBu-n)I,也可以通过依次用n -BuLi,CH 2(mim)2和碘对羰基铁进行处理而获得。另外,CH 2(3,5-Me 2 Pz)(Py)与n -BuLi,羰基铁和碘的连续反应生成(3,5-二甲基吡唑-1-基)(2-吡啶基)酰基铁络合物。相应的戊酰基铁络合物CH 2(3,5--ME 2 PZ)(PY)的Fe(CO)2(COBu- Ñ)当铁羰基进行反应我获得具有Ñ正丁基锂,随后用CH
  • (Pyrazol-1-yl)carbonyl and Ester-Functionalized Bis(pyrazol-1-yl)methide Carbonyl Tungsten Complexes
    作者:Jian-Peng Sun、Da-Wei Zhao、Hai-Bin Song、Liang-Fu Tang
    DOI:10.1021/om500639f
    日期:2014.9.8
    l)carbonyl- and n-butoxycarbonyl-functionalized bis(3,5-dimethylpyrazol-1-yl)methide carbonyl tungsten derivatives were unexpectedly formed, together with a bis(3,5-dimethylpyrazol-1-yl)acyl carbonyl tungsten complex, upon sequential treatment of bis(3,5-dimethylpyrazol-1-yl)methane with n-BuLi, tungsten carbonyl, and iodine. The resulting complexes were fully characterized using IR and NMR spectroscopy
    意外地形成了(3,5-二甲基吡唑-1-基)羰基和正丁氧基羰基官能化的双(3,5-二甲基吡唑-1-基)甲基羰基钨衍生物以及双(3,5-二甲基吡唑-在用正丁基锂,羰基钨和碘依次处理双(3,5-二甲基吡唑-1-基)甲烷后,制备1-基)酰基羰基钨络合物。使用IR和NMR光谱对得到的络合物进行了充分表征,并且通过X射线晶体学法明确地确定了它们的结构。
  • Synthesis and Spectroscopic Characterization of Copper(II)−Nitrito Complexes with Hydrotris(pyrazolyl)borate and Related Coligands
    作者:Nicolai Lehnert、Ursula Cornelissen、Frank Neese、Tetsuya Ono、Yuki Noguchi、Ken-ichi Okamoto、Kiyoshi Fujisawa
    DOI:10.1021/ic0619355
    日期:2007.5.1
    focuses on the geometric (molecular) structures, spectroscopic properties, and electronic structures of copper(II)-nitrito complexes as a function of second coordination sphere effects using a set of closely related coligands. With anionic hydrotris(pyrazolyl)borate ligands, one nitrite is bound to copper(II). Depending on the steric demand of the coligand, the coordination mode is either symmetric or asymmetric
    这项研究的重点是使用一组紧密相关的大肠菌素,作为第二配位球效应的函数,铜(II)-亚硝基络合物的几何(分子)结构,光谱性质和电子结构。对于阴离子的氢三(吡唑基)硼酸酯配体,亚硝酸盐与铜(II)结合。根据大分子的空间需求,配位模式可以是对称或不对称的二齿,这会导致生成的复合物具有不同的基态,从EPR光谱学可以明显看出。这些化合物的振动光谱通过同位素取代和DFT计算确定。结果表明,nu sym(NO)的能量高于nu asym(NO)的能量,这与相关化合物的文献资料不同。借助TD-DFT计算,介绍并分析了UV-vis吸收和MCD光谱。还应用DFT研究了亚硝酸盐与Cu(II)和Cu(I)的主要结合方式。使用中性的三(吡唑基)甲烷配体,将两个亚硝酸盐配体结合到铜上。在这种情况下,观察到非常不寻常的结合模式,其中一个亚硝酸盐是eta1-O结合的,另一个是eta1-N结合的。这使得可以研究配位亚硝酸盐的
  • Examining the impact of steric and electronic variation in N2S scorpionate ligands on the properties of zinc(II) and cadmium(II) complexes
    作者:Nicholas G. Spiropulos、G.C. Chingas、Mallory Sullivan、John T. York、Eric C. Brown
    DOI:10.1016/j.ica.2011.07.033
    日期:2011.10
    Abstract A series of LZn(II)Br (1–4) and LCd(II)Cl complexes (9–11) has been prepared by the reaction of metal halide precursors with the lithium salts of the N2S− ligands bis(3,5-diisopropylpyrazol-1-yl)dithioacetate (L1), bis(3,5-di-tert-butylpyrazol-1-yl)dithioacetate (L2), N-phenyl-2,2-bis(3,5-diisopropylpyrazol-1-yl)thioacetamide (L3) and N-phenyl-2,2-bis(3,5-di-tert-butylpyrazol-1-yl)thioacetamide
    摘要通过金属卤化物前体与N2S-配体bis(3,5)的锂盐反应,制备了一系列LZn(II)Br(1-4)和LCd(II)Cl配合物(9-11) -二异丙基吡唑-1-基)二硫代乙酸酯(L1),双(3,5-二叔丁基吡唑-1-基)二硫代乙酸酯(L2),N-苯基-2,2-双(3,5-二异丙基吡唑-1) -基)硫代乙酰胺(L3)和N-苯基-2,2-双(3,5-二叔丁基吡唑-1-基)硫代乙酰胺(L4)。通过X射线晶体学和DOSY NMR研究表明,LZnBr配合物1-4在固态和在溶液中均为单核。配体L1–L4之间的立体差异会导致每个复合物的理想四面体几何形状发生畸变,畸变程度取决于配体取代基的体积。相比之下,X射线晶体学显示相关的配合物L3CdCl在固态下二聚,形成氯桥联的五配位配合物[L3CdCl] 2(10)。尽管有10种固态双核结构,但DOSY NMR研究表明,溶液中存在9-11种单核LCdCl物
  • Mononuclear and Binuclear Copper(I) Complexes Ligated by Bis(3,5-diisopropyl-1-pyrazolyl)methane:  Insight into the Fundamental Coordination Chemistry of Three-Coordinate Copper(I) Complexes with a Neutral Coligand
    作者:Kiyoshi Fujisawa、Yuki Noguchi、Yoshitaro Miyashita、Ken-ichi Okamoto、Nicolai Lehnert
    DOI:10.1021/ic7011342
    日期:2007.12.1
    very unstable, leading to the formation of a binuclear complex (5ClO4) with one bridging perchlorate anion, such that the copper(I) centers are four-coordinate. The same tendency is observed for the copper(II) bis(mu-hydroxo) compounds 6, which is additionally bridged by two perchlorate anions. Both copper(II) complexes 6 and 7 were obtained by molecular O2 oxidation of the corresponding copper(I)
    通过使用中性双齿含氮配体双(3,5-二异丙基-1-吡唑基)甲烷(L1''),铜(I)络合物[Cu(L1'')2](CuCl2)(1CuCl2) ,[Cu(L1'')2](ClO4)(1ClO4),[Cu(L1'')] 2(ClO4)2(2ClO4),[Cu(L1'')] 2(BF4)2(2BF4) ,[Cu(L1'')(NCMe)](PF6)(3PF6),[Cu(L1'')(PPh3)](ClO4)(4ClO4),[Cu(L1'')(PPh3)](PF6 )(4PF6),[Cu(L1'')(CO)} 2(mu-ClO4)](ClO4)(5ClO4)和铜(II)络合物[Cu(L1'')} 2(mu系统合成了-OH)2(mu-ClO4)2](6)和[Cu(L1'')Cl2](7),并通过X射线晶体学,IR和1H NMR光谱对其进行了全面表征。在铜(II)的情况下,也应用了ESR光谱。与相关
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺